Peginterferon alfa-2b Alternatives Compared
| Peginterferon alfa-2b | Ledipasvir / sofosbuvir | Harvoni (ledipasvir / sofosbuvir) |
|
|---|
| Peginterferon alfa-2b | Ledipasvir / sofosbuvir | Harvoni (ledipasvir / sofosbuvir) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatitis C, Chronic Myelogenous Leukemia, Hepatitis B, Melanoma, Melanoma - Metastatic, Renal Cell Carcinoma, Thrombocythemia. Peginterferon alfa-2b may also be used for purposes not... View more |
Prescription only
Prescribed for Hepatitis C. Ledipasvir / sofosbuvir may also be used for purposes not listed in this medication guide. |
Prescription only
Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Related suggestions Hepatitis C
|
|||||||||||||||
| More about Peginterferon alfa-2b | More about Ledipasvir / sofosbuvir | More about Harvoni (ledipasvir / sofosbuvir) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Peginterferon alfa-2b has an average rating of 7.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ledipasvir / sofosbuvir has an average rating of 8.5 out of 10 from a total of 411 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 10% reported a negative effect. |
Harvoni has an average rating of 8.6 out of 10 from a total of 402 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ledipasvir / sofosbuvir prices |
View all Harvoni prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| PegIntron, Sylatron | Harvoni |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
60 hours |
47 hours |
47 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 216 drugs are known to interact with Peginterferon alfa-2b:
|
A total of 175 drugs are known to interact with Ledipasvir / sofosbuvir:
|
A total of 175 drugs are known to interact with Harvoni:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
October 10, 2014 |
October 10, 2014 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.